BlockBeats News, March 21st, Biopharmaceutical publicly traded company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy, with plans to initially invest $5 million to purchase Bitcoin. In response to this news, ATAI's stock price briefly increased. The company's Chairman, Christian Angermayer, stated that the company plans to initially invest $5 million to purchase Bitcoin while also maintaining sufficient cash, short-term securities, and publicly traded equity to secure the company's operating funds until 2027.
